Journal of Antimicrobial Chemotherapy, Vol 40, 235-240, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
Y Irie, K Tateda, T Matsumoto, S Miyazaki and K Yamaguchi
We compared the susceptibility of Helicobacter pylori to several
antibiotics, expressed as MICs and as bactericidal effectiveness in short
(3 h) time-killing studies. Of the antimicrobial agent tests,
clarithromycin and amoxycillin had the lowest MIC50, 0.063 and 0.125 mg/L
respectively, for 24 strains of H. pylori. Minocycline, levofloxacin and
lansoprazole followed, with MIC50s of 0.5, 1, and 2 mg/L, respectively.
Three-hour time-killing studies using a standard strain demonstrated a
different pattern. At 4 x MIC, kanamycin, metronidazole and clarithromycin
produced 4.4, 2.6 and 2.1 log decreases in viability, whereas the remaining
seven antibiotics (including amoxycillin) were less bactericidal.
Amoxycillin's lack of bactericidal activity during brief incubations was
confirmed by examining several different clinically isolated H. pylori
strains. Clarithromycin's effect, on the other hand, was strain- and
concentration-dependent. Kanamycin was the most potent antibiotic in short
time-killing studies, with concentrations of 1 x MIC and 4 x MIC producing
a reduction of more than 2 and 4 log respectively in all ten strains. Our
data suggest that the MIC of antimicrobial agents against H. pylori does
not necessarily predict their activity in short time- killing studies.
Furthermore, our short time-kill data suggest kanamycin as a potential
therapeutic choice for H. pylori infection, even though this agent's MIC
would suggest limited activity.
ORIGINAL ARTICLES
Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin
Third Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Lozniewski, A. Duprez, C. Renault, F. Muhale, M.-C. Conroy, M. Weber, A. Le Faou, and F. Jehl Gastric Penetration of Amoxicillin in a Human Helicobacter pylori-Infected Xenograft Model Antimicrob. Agents Chemother., August 1, 1999; 43(8): 1909 - 1913. [Abstract] [Full Text] |
||||
